AZTR Rasio cepet Azitra, Inc.

The Azitra, Inc. (AZTR) price chart on the GURU.Markets platform demonstrates stability amid the absence of political risks in the US, while the separate_ratio_quick indicator stands at 4.65. The business relies on the development of bacterial treatments for rare skin pathologies and FDA approval. However, the project's success depends on competing with cosmetic behemoths in the field of microbiome innovations.

Azitra, Inc. (AZTR) is developing gene therapies for skin pathologies, currently generating no sales and remaining dependent on research outcomes. By analyzing the quick ratio, an investor can assess the company's ability to meet short-term obligations using cash and accounts receivable. Excluding inventories makes the calculation maximally conservative, separating liquid assets from less marketable resources. This metric determines the business's financial cushion until the next funding round.